HETASTARCH IN SODIUM CHLORIDE (Hospira, Inc.)


Welcome to the PulseAid listing for the HETASTARCH IN SODIUM CHLORIDE drug offered from Hospira, Inc.. This Plasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA],Starch [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Hospira, Inc.
NON-PROPRIETARY NAME: HETASTARCH
SUBSTANCE NAME: HETASTARCH
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Plasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA],Starch [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2005-05-26
END MARKETING DATE: 0000-00-00


HETASTARCH IN SODIUM CHLORIDE HUMAN PRESCRIPTION DRUG Details:

Item DescriptionHETASTARCH IN SODIUM CHLORIDE from Hospira, Inc.
LABELER NAME: Hospira, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 6(g/100mL)
START MARKETING DATE: 2005-05-26
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0409-7248_25e5dcb2-4a6b-4d84-b4f1-da17f0931bff
PRODUCT NDC: 0409-7248
APPLICATION NUMBER: BA740193

Other HETASTARCH Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Hospira, Inc.Hextend